Overexpression of transforming growth factor-α and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters

Carcinogenesis

Volumn 17, Issue 4, 1996, Pages 779-785

  Visser, C J T ^a,b   Bruggink, A H ^b   Korc, M ^c   Kobrin, M S ^c   De Weger, R A ^b   Seifert Bock, I ^b   Van Blokland, W T M ^b   Van Garderen Hoetmer, A ^a   Woutersen, R A ^a  

^a TNO   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; CERULETIDE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HAMSTER; IMMUNOHISTOCHEMISTRY; LIPID DIET; NONHUMAN; NORTHERN BLOTTING; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; BLOTTING, NORTHERN; BODY WEIGHT; CARCINOGENS; CRICETINAE; EPIDERMAL GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; MESOCRICETUS; NITROSAMINES; ORGAN SIZE; PANCREAS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0029873613     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.4.779     Document Type: Article

References (37)

1. Warshaw,A.L. and Fernandez del Castillo,C. (1992) Pancreatic carcinoma. New Engl J. Med., 326, 455-465.
2. Simon,B., Weinel,R., Höhne,M., Watz,J., Schmidt,J., Kortner,G. and Arnold,R. (1994) Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. Gastroenterology, 106, 1645-1651.
3. Berrozpe,G., Shaeffer,J., Peinado,M.A., Real,F.X. and Perucho,M. (1994) Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int. J. Cancer, 58, 186-191.
4. Grunewald,K , Lyons,J., Fröhlich,A., Feichtinger,H., Weger,R.A., Schwab,G., Janssen,J W.G. and Bartram,C.R. (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer. 43, 1037-1041.
5. Caldas,C. et al (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTSI) gene in pancreatic adenocarcinoma. Nature Genet., 8, 27-32.
6. Cerny,W.L., Mangold,K.A. and Scarpelli,D.G. (1992) K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res., 52, 4507-4513.
7. Korc,M., Chandrasekar,B , Yamanaka,Y., Friess,H , Büchler,M. and Beger,H G. (1992) Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest., 90, 1352-1360.
8. Ebert,M., Yokoyama,M., Friess,H., Buchler,M.W and Korc,M. (1994) Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res., 54, 5775-5778.
9. Yamanaka,Y., Friess,H., Kobrin,M.S., Buchler,M., Kunz,J., Beger,H.G. and Korc,M. (1993) Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum. Pathol., 24, 1127-1134.
10. Friess,H., Yamanaka,Y , Buchler,M., Beger,H.G., Kobrin,M.S., Baldwin,R L and Korc,M (1993) Enhanced expression of the type II transforming growth factor-β receptor in human pancreatic cancer without alteration of type III receptor expression. Cancer Res., 53, 2704-2707.
11. Kobrin,M S., Yamanaka,Y., Friess,H., Lopez,M.E. and Korc,M (1993) Aberrant expression of the type I fibroblast growth factor receptor in human pancreatic adenocarcinoma. Cancer Res., 53, 4741-4744.
12. Hoey,J (1985) Cancer of the pancreas, epidemiology and risk factors. Gastroenterol Clin Biol., 9, 756-766.
13. Silverman,D.T. et al. (1994) Cigarette smoking and pancreas cancer a case-control study based on direct interviews. J. Natl Cancer Inst., 86, 1510-1516.
14. Ghadirian,P., Thouez,J.P. and PetitClerc,C. (1991) International comparisons of nutrition and mortality from pancreatic cancer. Cancer Detect. Prevent., 15, 357-362.
15. Birt,D.F., Salmasi,S. and Pour,P.M. (1981) Enhancement of experimental pancreatic cancer in Synan golden hamsters by dietary fat. J. Natl Cancer Inst., 67, 1327-1332.
16. Birt,D.F., Stepan,K.R. and Pour,P.M. (1983) Interaction of dietary fat and protein on pancreatic carcinogenesis in Syrian golden hamsters. J. Natl Cancer Inst., 71, 355-360.
17. Longnecker,D.S., Roebuck,B.D. and Kuhlmann,E.T. (1985) Enhancement of pancreatic carcinogenesis by dietary unsaturated fat in rats treated with saline or N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine. J. Natl Cancer Inst., 74, 219-222
18. Woutersen,R.A., van Garderen-Hoetmer,A., Bax,J. and Scherer,E. (1989) Modulation of dietary fat-promoted pancreatic carcinogenesis in rats and hamsters by chronic ethanol ingestion. Carcinogenesis, 10, 453-459.
19. Lhoste,E.F. and Longnecker,D.S. (1987) Effects of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas. Cancer Res., 47, 3273-3277.
20. Douglas,B R., Woutersen,R.A , Jansen,J.B.M.J., Rovati,L.C. and Lamers, C.B.H.W. (1989) The effect of cholecystokinin and bombesin on pancreatic carcinogenesis in the rat, studies into the modulating effect of a new cholecystokinin receptor antagonist. Gastroenterology, 96, 462-469.
21. Pour,P.M. et al. (1981) Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer, 47, 1573-1587.
22. Visser,C.J.T., Woutersen,R.A., Bruggink,A.H., van Garderen-Hoetmer,A., Seifert-Bock,I., Tilanus,M.G.J. and De Weger,R.A. (1995) Transforming growth factor-α and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats; modulation by cholecystokinin or a low fat-high fiber (caloric restricted) diet. Carcinogenesis. 16, 2075-2082.
23. Pour,P.M., Lawson,T., Helgeson,S., Donelly,T. and Stepan,K. (1988) Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model. Carcinogenesis, 9, 597-601.
24. Meijers,M., van Garderen-Hoetmer,A., Lamers,C.B.H.W., Rovati,L.C., Jansen,J.B.M.J. and Woutersen,R.A. (1990) Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters. Carcinogenesis, 11, 2223-2226.
25. Howatson,A.G. and Carter,D.C. (1985) Pancreatic carcinogenesis; enhancement by cholecystokinin in the hamster-nitrosamine model. Br. J. Cancer, 51, 107-114.
26. Pour,P.M. and Wilson,R B. (1980) Experimental pancreatic tumors. In Moossa,A.R. (ed.), Tumors of the Pancreas. Williams and Wilkins, Baltimore, MD, pp. 37-158.
27. Roy,S.K. and Greenwald,G.S. (1990) Immunohistochemical localization of epidermal growth factor-like activity in the hamster ovary with a polyclonal antibody. Endocrinology, 126, 1309-1317.
28. Yura,Y., Hayashi,O., Kelly,M. and Oyasu,R. (1989) Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions. Cancer Res , 49, 1548-1553.
29. Wu,H.H., Kawamata,H , Wang,D.D. and Oyasu,R. (1993) Immuno-histochemical localization of transforming growth factor α in the major salivary glands of male and female rats. Histochem, J., 25, 613-618.
30. Visser,C J.T., De Weger,R.A., van Blokland,W.T.M., Seifert-Bock,I., Kobrin,M.S., Korc,M. and Woutersen,R.A. (1996) Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine. Br. J. Cancer, in press.
31. Woutersen,R.A., van Garderen-Hoetmer,A. and Longnecker,D.S. (1987) Characterization of a 4-months protocol for the quantitation of BOP-induced lesions in hamster pancreas and us application in studying the effect of dietary fat. Carcinogenesis, 8, 833-837.
32. Gamou,S., Kim,Y.S. and Shimizu,N. (1984) Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors. Mol. Cell. Endocrinol., 37, 205-213.
33. Lemoine,N.R., Hughes,C.M., Barton,C.M., Poulsom,R., Jeffery,R.E., Kloppel,G., Hall,P.A. and Gullick,W.J. (1992) The epidermal growth factor receptor in human pancreatic cancer. J. Pathol., 166, 7-12.
34. Korc,M., Chandrasekar,B., Yamanaka,Y., Friess,H., Buchler,M. and Beger,H.G. (1992) Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest., 90, 1352-1360.
35. Smith,J.J., Derynck,R. and Korc,M. (1987) Production of transforming growth factor α in human pancreatic cancer cells: evidence for a superagonistic autocrine cycle. Proc. Natl Acad. Sci. USA. 84, 7567-7570.
36. Schreiber,A.B., Winkler,M.E. and Derynck,R. (1986) Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science, 232, 1250-1253.
37. Derynck,R. (1986) Transforming growth factor-α: structure and biological activities. J. Cell Biol., 32, 293-304.